Posts Tagged: intellectual property
MaRS Innovation focus of Yonge Street Media article on growing technology sectors
President and CEO Dr. Raphael Hofstein speaks on healthcare innovation in Toronto
In an October 30 article, Yonge Street Media's Andrew Seale spoke with MI’s president and CEO Raphael Hofstein on the booming healthcare innovation coming from Toronto since 2005.
Seale's article is the first of a two-part series on technological innovation.
In the article, Hofstein credits the city’s intellectual infrastructure and access to healthcare resources for allowing innovation to flourish.
Three of MI’s start-up companies are also mentioned in the article.
Here’s an excerpt (links and ...
Read more
ChipCare’s handheld analyzer attracts one of Canada’s largest-ever healthcare angel investments
Device could significantly improve HIV diagnostics in developing world
OTTAWA, September 16, 2013 — An innovative, handheld point-of-care analyzer, developed by ChipCare Corporation, has secured one of the largest ever angel investments in Canada's healthcare sector.
Phase II financing has closed, with an investment of $2.05M to support ChipCare's continuing development and commercialization over the next three years.
Media coverage: Biotechnology Focus, TechVibes, BetaKit, Healthrender, Crunchbase, Toronto Star and VentureLab.
The financing evolved through a uniquely collaborative funding model among Canadian social angel investors, including ...
Read more
Dr. Hofstein’s Op-Ed for The Hill-Times, “Biotechnology research: A knowledge economy”
This op-ed on Canadian biotechnology and the knowledge economy appeared in The Hill-Times (subscription required), Canada's politics and government newsweekly, September 9:
Obesity, cancer, heart disease and stroke, diabetes, Parkinson’s disease, Alzheimer’s, or the more general stresses of an aging population: no matter which area of concern holds our collective gaze from moment to moment, improving health outcomes and healthcare is the No. 1 challenge for the world’s economy.
Canada has the holistic approach and translational research necessary to address health care’s pervasive ...
Read more
Five UTEST companies to tackle critical healthcare challenges
Program's second cohort includes eQOL, E-Twenty Development, Root2Crown, Treata Smart Solutions and TrendMD
TORONTO (May 14, 2013) — Five companies tackling pervasive healthcare challenges — such as assessing dental health, helping patients and medical personnel navigate hospitals with greater ease, staying current with medical literature, or creating digital tools to help care for the elderly or those with chronic health conditions — have been admitted to the University of Toronto Early Stage Technology (UTEST) program’s second cohort.
UTEST, supported by the University of ...
Read more
What does MaRS Innovation’s funding extension mean for Toronto’s academic entrepreneurs?
Every six weeks, MaRS Innovation's marketing and communications manager writes a guest post for the MaRS Discovery District blog profiling MI's activities or one of our start-up companies. You can read the original post on the MaRS blog.
Created in 2008, MaRS Innovation (MI) bridges the chasm between the early-stage technologies emerging from its 16 member institutions and successful startup companies and licensable technologies.
By offering early-stage funding in tandem with hands-on management, business development, mentorship and intellectual property protection strategy, MI acts as ...
Read more
MaRS Innovation awarded $15 million to further commercialize world-leading Canadian innovations
Networks of Centres of Excellence recognizes strength of partnership between MI and its 16 member institutions
TORONTO, February 5, 2013 — How do you make sure the brilliant ideas emerging from Toronto’s academic research community get the best possible chance to succeed?
MaRS Innovation (MI), created in 2008, bridges the chasm between these early-stage technologies and successful start-up companies and licensable technologies. By offering early-stage funding in tandem with hands-on management, mentorship and IP strategy protection, MI acts as a commercialization agent for ...
Read more
Shotlst: “Track changes” for the physical world
Shotlst is one of six inaugural UTEST companies; next UTEST application round to begin shortly
What if you could turn on Microsoft Word’s “track changes” tool and apply it at will to the world around you?
Sound like science fiction?
Meet Matt Ratto, a professor in the University of T’s Faculty of Information, and Mike Borg, a recent graduate of the faculty. They’ve formed Shotlst, a new software company being incubated by the University of Toronto Early Stage Technology (UTEST) program.
The central metaphor of ...
Read more
OICR and MaRS Innovation announce funding to develop Cellax™, a nanotechnology-based cancer drug
TORONTO, ON (November 13, 2012) — The Ontario Institute for Cancer Research (OICR) and MaRS Innovation (MI) today announced $1.5 million in funding from OICR over three years to further develop Cellax™, a nanoparticle drug that could offer an alternative to chemotherapy with fewer side effects.
“Cellax is promising because it provides a more targeted strategy for treating tumours, killing tumour cells while minimizing the effect on healthy tissue,” said Dr. Rima Al-awar, director, OICR’s Medicinal Chemistry Platform. “OICR is proud to ...
Read more
VP Joel Liederman: MaRS Innovation, Canadian Research and the Commercialization Test
Joel Liederman, MaRS Innovation’s vice-president of Business Development and Physical Sciences, was quoted in a National Post article, published August 13, probing whether Canadian research is passing the commercialization test.
Here's an excerpt:
While academics have often been accused of being disconnected from the real world and consuming themselves with the theoretical, it’s hard to imagine they would be able to get away with squandering funding dollars on things that make them go hmmm, particularly in light of the hyper focus on fiscal ...
Read more
Video: Canadian International Council interviews Rafi Hofstein about commercializing Canadian technology
Dr. Raphael Hofstein, president and CEO of MaRS Innovation, spoke to the Canadian International Council about the importance of protecting intellectual property as an important component in commercializing Canadian technologies.
Here's an excerpt:
Government could be extremely helpful if they created special funds dedicated to covering the costs of patent protection.
(more…)
Read more